Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Psychotropic
  3. Practical information on using psychotropics
  4. Psychotropic use in females of childbearing potential
  5. References
  6. References: Suvorexant use in females of childbearing potential
  • Psychotropic
    • Informed consent and shared decision making for a person with a psychiatric disorder
    • Acute behavioural disturbance
    • Anxiety and associated disorders
    • Attention deficit hyperactivity disorder
    • Challenging behaviour in autism spectrum disorder
    • Bipolar disorder
    • Delirium
    • Dementia
    • Depressive disorders
    • Disruptive behaviour disorders
    • Eating disorders
    • Grief
    • Insomnia, circadian rhythm disorders and parasomnias
    • Personality disorder
    • Psychoses
    • Postpartum psychosis
    • Suicide risk
    • Tourette syndrome
    • Trauma- and stressor-related disorders
    • Practical information on using psychotropics
      • Off-label prescribing for psychiatric disorders
      • Adherence to psychotropics
      • Psychotropic use in children
      • Psychotropic use in females of childbearing potential
        • What is covered in this topic?
        • Principles of psychotropic use in females of childbearing potential
        • Antidepressant use in females of childbearing potential
        • Antiepileptic use for psychiatric disorders in females of childbearing potential
        • Antipsychotic use in females of childbearing potential
        • Benzodiazepine, zolpidem or zopiclone use in females of childbearing potential
        • Lisdexamfetamine use for psychiatric disorders in females of childbearing potential
        • Lithium use in females of childbearing potential
        • Suvorexant use in females of childbearing potential
        • Complementary medicine use for psychiatric disorders in females of childbearing potential
        • References
          • References: Principles of psychotropic use in females of childbearing potential
          • References: Antidepressant use in females of childbearing potential
          • References: Antiepileptic use for psychiatric disorders in females of childbearing potential
          • References: Antipsychotic use in females of childbearing potential
          • References: Benzodiazepine, zolpidem or zopiclone use in females of childbearing potential
          • References: Lisdexamfetamine for psychiatric disorders in females of childbearing potential
          • References: Lithium use in females of childbearing potential
          • References: Suvorexant use in females of childbearing potential
          • References: Complementary medicine use for psychiatric disorders in females of childbearing potential
      • Psychotropic use during pregnancy
      • Psychotropic use while breastfeeding
      • Antidepressant adverse effects
      • Switching antidepressants
      • Stopping an antidepressant
      • Principles of using irreversible nonselective monoamine oxidase inhibitors (MAOIs)
      • Principles of antipsychotic use
      • Antipsychotic adverse effects
      • Switching antipsychotics
      • Stopping an antipsychotic
    • Nonpharmacological therapies for psychiatric disorders

References: Suvorexant use in females of childbearing potential

  • Keks NA, Hope J, Keogh S. Suvorexant: scientifically interesting, utility uncertain. Australas Psychiatry 2017;25(6):622–4. https://www.ncbi.nlm.nih.gov/pubmed/28994603
  • Sutton EL. Profile of suvorexant in the management of insomnia. Drug Des Devel Ther 2015;9:6035–42. https://www.ncbi.nlm.nih.gov/pubmed/26648692
  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)